Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.

Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 2001 Nov 22;44(24):4230-51.

PMID:
11708925
2.

Indazole estrogens: highly selective ligands for the estrogen receptor beta.

De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 2005 Feb 24;48(4):1132-44.

PMID:
15715479
3.

Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.

Güngör T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.

J Med Chem. 2006 Apr 20;49(8):2440-55.

PMID:
16610787
4.

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.

Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 1999 Jul 1;42(13):2456-68.

PMID:
10395487
5.

Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.

Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS.

Mol Cell Endocrinol. 2003 Aug 29;206(1-2):13-22.

PMID:
12943986
6.

Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.

Ghosh U, Ganessunker D, Sattigeri VJ, Carlson KE, Mortensen DJ, Katzenellenbogen BS, Katzenellenbogen JA.

Bioorg Med Chem. 2003 Feb 20;11(4):629-57.

PMID:
12538029
7.

Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.

Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 2004 Nov 18;47(24):5872-93. Erratum in: J Med Chem. 2005 Apr 7;48(7):2724.

PMID:
15537344
8.

Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction.

Stauffer SR, Sun J, Katzenellenbogen BS, Katzenellenbogen JA.

Bioorg Med Chem. 2000 Jun;8(6):1293-316.

PMID:
10896109
9.

Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.

Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.

Biochem Pharmacol. 2006 May 14;71(10):1459-69. Epub 2006 Mar 22.

PMID:
16554039
10.

6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.

Sun W, Cama LD, Birzin ET, Warrier S, Locco L, Mosley R, Hammond ML, Rohrer SP.

Bioorg Med Chem Lett. 2006 Mar 15;16(6):1468-72. Epub 2006 Jan 18.

PMID:
16412638
11.

Synthesis and evaluation of aryl-substituted diarylpropionitriles, selective ligands for estrogen receptor beta, as positron-emission tomographic imaging agents.

Moon BS, Carlson KE, Katzenellenbogen JA, Choi TH, Chi DY, Kim JY, Cheon GJ, Koh HY, Lee KC, An G.

Bioorg Med Chem. 2009 May 1;17(9):3479-88. doi: 10.1016/j.bmc.2009.02.064. Epub 2009 Mar 9.

PMID:
19359182
12.

Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.

Minutolo F, Antonello M, Bertini S, Rapposelli S, Rossello A, Sheng S, Carlson KE, Katzenellenbogen JA, Macchia M.

Bioorg Med Chem. 2003 Apr 3;11(7):1247-57.

PMID:
12628652
13.

A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta.

Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.

J Med Chem. 2002 Dec 5;45(25):5492-505.

PMID:
12459017
14.

Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.

Mortensen DS, Rodriguez AL, Carlson KE, Sun J, Katzenellenbogen BS, Katzenellenbogen JA.

J Med Chem. 2001 Nov 8;44(23):3838-48.

PMID:
11689070
16.

Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.

Hsieh RW, Rajan SS, Sharma SK, Guo Y, DeSombre ER, Mrksich M, Greene GL.

J Biol Chem. 2006 Jun 30;281(26):17909-19. Epub 2006 Apr 28.

17.

Molecular basis for the subtype discrimination of the estrogen receptor-beta-selective ligand, diarylpropionitrile.

Sun J, Baudry J, Katzenellenbogen JA, Katzenellenbogen BS.

Mol Endocrinol. 2003 Feb;17(2):247-58.

PMID:
12554752
18.

Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) alpha and beta.

Mueller SO, Hall JM, Swope DL, Pedersen LC, Korach KS.

J Biol Chem. 2003 Apr 4;278(14):12255-62. Epub 2003 Jan 22.

19.

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.

J Med Chem. 2004 Oct 7;47(21):5021-40.

PMID:
15456246
20.

Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.

Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.

J Med Chem. 2005 Jan 27;48(2):364-79.

PMID:
15658851

Supplemental Content

Support Center